Frontiers in Pharmacology·Nov 22Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signalingExperiments in animalsBones and jointsPaper